Pharmacological properties of SDZ 208-912: a potential high potency, non-classical neuroleptic.
Coward
D M
DM
Sandoz Research Institute Berne Ltd., Switzerland.
Dixon
A K
AK
Urwyler
S
S
Vigouret
J M
JM
D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism / Q000494:pharmacology*; D002417:Cattle; D004873:Ergolines / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006220:Haloperidol / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D011388:Prolactin / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000378:metabolism
D014150:Antipsychotic Agents; D004873:Ergolines; D011985:Receptors, Serotonin; C059362:N-(2-chloro-6-methylergoline-8-yl)-2,2-dimethylpropanamide; D011388:Prolactin; D006220:Haloperidol